Second-Generation Antipsychotic Medications and Risk of Pneumonia in Schizophrenia

By Kuo Chian-Jue   Yang Shu-Yu   Liao Ya-Tang   Chen Wei J.   Lee Wen-Chung   Shau Wen-Yi   Chang Yao-Tung   Tsai Shang-Ying   Chen Chiao-Chicy  

Schizophrenia Bulletin, Vol. 39, Iss. 3, 2013-05 ,pp. : 648-657

Oxford University Press

Access to resources Recommend Favorite

Sexual function of patients with schizophrenia receiving first-generation (FGA) or second-generation antipsychotic (SGA) treatment

By Mahmoud Ahmed  

Primary Care Psychiatry, Vol. 16, Iss. 2, 2012-06 ,pp. : 148-152

Informa Healthcare

Access to resources Recommend Favorite

Sexual function of patients with schizophrenia receiving first-generation (FGA) or second-generation antipsychotic (SGA) treatment

By Mahmoud Ahmed   Hayhurst Karen P.   Drake Richard J.   Lewis Shôn W.  

International Journal of Psychiatry in Clinical Practice, Vol. 16, Iss. 2, 2012-06 ,pp. : 148-152

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Metabolic Risk with Second-Generation Antipsychotic Treatment: A Double-Blind Randomized 8-Week Trial of Risperidone and Olanzapine

By Kelly Deanna  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 20, Iss. 2, 2008-05 ,pp. : 71-78

Informa Healthcare

Access to resources Recommend Favorite

What is the evidence for the use of second-generation antipsychotic long-acting injectables as maintenance treatment in bipolar disorder?

By Samalin Ludovic   Nourry Aurore   Charpeaud Thomas   Llorca Pierre-Michel  

Nordic Journal of Psychiatry, Vol. 68, Iss. 4, 2014-05 ,pp. : 227-235

Informa Healthcare

Access to resources Recommend Favorite